Carlini, Sara V.
Weiss, Sandra J.
Mordukhaev, Lauren
Jacob, Sunu
Flynn, Heather A.
Deligiannidis, Kristina M. https://orcid.org/0000-0001-7439-2236
Funding for this research was provided by:
National Network of Depression Centers
Feinstein Institutes for Medical Research
Article History
Received: 30 May 2022
Accepted: 17 October 2022
First Online: 8 November 2022
Declarations
:
: the present study protocol, IRB # 18-0107, was deemed exempt under 45 CFR 46.101(b)(2) by the Institutional Review Board of the Office of the Human Research Protection Program at Northwell Health, FWA #00002505.
: Not applicable.
: The authors declare that there are no conflicts of interests. Dr. Deligiannidis receives separate research grant support from the National Institutes of Health (R01MH120313), Sage Therapeutics, and Vorso Corporation, serves as a consultant to Sage Therapeutics and Brii Biosciences, and receives royalties from an National Institutes of Health Employee Invention. During the course of this study, Dr. Weiss received separate research funding from the National Institutes of Health (R01HD081188, R01HD084813, T32NR016920) and the Robert and Delphine Wentland Eschbach Endowment.